On June 4, Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Incyte Corporation (NASDAQ:INCY) with a price target of $68.00. The analyst based his rating on several factors ...

It has been about a month since the last earnings report for Incyte (INCY). Shares have added about 3.6% in that time frame, underperforming the S&P 500. Will the recent positive trend continue ...

Despite the more favorable entry price, we're cautious about Incyte. Here are three reasons why INCY doesn't excite us and a stock we'd rather own. Adjusted operating margin is one of the best ...

One contestant, Sharon, explained her mistake to Lee: "I put Incy Wincy as he is a spider and the rest are all sort of people." This prompted many players to laugh, with Lee seizing the chance to ...

Across the recent three months, 8 analysts have shared their insights on Incyte INCY, expressing a variety of opinions spanning from bullish to bearish. The table below provides a concise overview ...

One contestant, Sharon, explained why she'd answered the question wrong. She told Lee: "I put Incy Wincy as he is a spider and the rest are all sort of people." This prompted many players to laugh ...

In this article, we are going to take a look at where Incyte Corporation (NASDAQ:INCY) stands against other small-cap healthcare stocks hedge funds are buying. The U.S. healthcare sector has ...

What is the current share price of Incyte Corp (INCY)? Incyte Corp's (INCY) current share price is $64.25. This constitutes a price movement of 1.48% when compared to the share price 7 days ago and is ...

The 100 contestants were then given two options to choose from as the next item in the list: 'Postman Pat' or 'Incy Wincy'. While the contestants were thinking hard, Lee cheekily quipped ...

Incyte (NASDAQ:INCY) and Novartis AG (NYSE:NVS) reached a settlement regarding royalty payments in an existing collaboration between the companies for blood-cancer treatment Jakafi. In a filing on ...